FDA | Latest updated news - Page 1

The use of Johnson & Johnson is halted in The US, South Africa and European Union after six women in the U.S. developed a rare blood-clotting disorder upon receiving the vaccine.

Amid the rising of the new Covid-19 variants that threat millions of lives, one of strongest weapons that might help curbing the spread of the variants in the United States and worldwide may be a vaccine that the FDA hasn't approved yet.

The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday (August 05).

Health officials from the US have approved the first game-based treatment for children with attention deficit hyperactivity disorder, part of a trend toward "digital therapeutics" or software to address certain conditions.